Pulmonary Hypertension

Clinical Trials

Below is a list of Pulmonary Hypertension clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Drug Therapy for the Treatment of Pulmonary Arterial Hypertension Associated with Idiopathic Pulmonary Fibrosis
The purpose of this research study is to determine the following:

• To find out what effects (good and bad) the drug Bosentan has on you and your idiopathic pulmonary fibrosis and pulmonary hypertension.
• Measure substances in the blood to determine if these substances contribute to the development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension PAH Disease Management
This study is being done to better understand the medical management of patients with a new or existing diagnosis of PAH. Other objectives include describing the demographic and clinical characteristics of PAH patients as well as identifying medical practices associated with improved health outcomes. This study will collect information on approximately 3,000 patients with PAH at approximately 50 sites in the United States. Data will be collected on patients for at least five years, including past data, if applicable (data from medical records that were recorded prior to the start of the REVEAL Registry) and follow-up telephone and clinic visit data.

As this is an information-gathering study only, your physician will manage your care no differently than he/she would if you were not part of this registry program. You do not need to participate in the REVEAL Registry to receive treatment for your condition. Participating in the REVEAL Registry will not influence the usual care that you receive from your doctor. Specifically, the care you receive from your doctor while participating in the REVEAL Registry will be the same as the care you would receive if you were not participating in this research program.
Read more